NCT04694638View on ClinicalTrials.gov

Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

May 10, 2023

Study Completion Date

May 10, 2023

Conditions
Prone PositioningCovid19Hypoxemic Respiratory FailureARDSNon Invasive VentilationHigh Flow Nasal Cannulla
Interventions
OTHER

Body position change

combined use of prone positioning and high-flow nasal cannula (HFNC) and non-invasive positive pressure ventilation (NIPPV) can reduce the rate of intubation in acute hypoxemic and/or hypercapnic respiratory failure secondary to COVID-19 infection.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04694638 - Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection | Biotech Hunter | Biotech Hunter